PSA Prostate Cancer Screening – Who Needs It?

This article contains very important tips on the screening and treatment of prostate cancer. Prostate cancer is one disease that usually develops so slowly that it may not produce any noticeable symptoms in its early stages. Actually, as a matter of fact, there are indeed no early symptoms of the disease, and on several instances, victims are not even aware of the disease until they begin to feel pain in urination and in ejaculation. By this time, they can see blood in their semen as well, which often implies that the disease is becoming metastatic ? and I tell you, you don’t want metastatic. The screening tests are just about the only way to can detect precancerous metastasis and prostate cancer in an early, and easily treatable, stage.

There are all kinds of screening tests for early detection of all kinds of cancers ? the cervix, breast, and colon and rectum (colorectal cancer); and researchers are taking no chances, they are constantly making much progress in identifying all kinds of cancer genes associated with an increased risk of the disease, and with these they are developing even more screening tests for precisely those cancer genes.

One American study considered the general effectiveness of a PSA (prostate specific antigen) screening program back in early 2000s, using close to eighty thousand men as various study centers around the country. About half of them got annual PSA testing for 6 years, and the other half got what we will call the ‘usual care’, for the same period of time. After 7 years of follow-up, the first half had more cancer patients than the second, and there also were regrettably more deaths in the first group as well ? the screening group. However, the differences weren’t so alarming as to point to anything in particular, and our researchers put them down as negligible.

In all of these prostate cancer screening tests, what they are looking at is the PSA ratio in one party to compare to the other. For a fact, the higher the prostate specific antigen count in a patient’s blood sample, the higher the chances that they have prostate cancer, and also the higher the possibility that that disease has metastasized to other parts of the body. However, because the PSA count is not always conclusive of prostate cancer, it is not used alone in the diagnosis, in the screening, or in the staging of the disease ? a number of other tests are included in the process before satisfactory answers are gotten.

It is critical to do the screening and all of these PSA and other tests because they are what determine the type and aggressiveness of the treatment that is going to be administered to the patient. There is no absolutely certain way to be sure that a successfully treated prostate cancer condition will not relapse, but from experience, several oncologists can guess it by a combination intuition and the facts that they have gotten from the tests. Even after then, they still have to watch you closely. No questions asked, it is you, the prostate cancer patient, who needs the screening tests the most.

To read specifically about prostate cancer screening Gelmann or prostate cancer screening guidelines, see the particular article about each of these in the “related articles” section.

1. Why Prostate Cancer Screening Programs Are Important
2. Why You Should Do A Prostate Cancer Psa Test Today
3. Prostate Cancer Symptoms Screening and Diagnosis
4. What You Should Know About PSA Test For Prostate Cancer
5. Are You This Wrong About Prostate Cancer Screening?